B2i Digital Hosts Life Sciences Virtual Investor Forum June 24-25

B2i Digital, Inc. has announced the Life Sciences Virtual Investor Forum, a two-day event on June 24 and 25, 2026, co-hosted by Virtual Investor Conferences and Zacks Small-Cap Research. As the Official Marketing Partner, B2i Digital leverages its distribution engine to drive qualified investors from its proprietary network of over 1.7 million market participants to the event. The forum features presentations from over 20 public companies spanning clinical-stage biotechnology, rare-disease and oncology therapeutics, molecular diagnostics, medical devices, veterinary medicine, nutrition science, and AI-powered digital health. Key players include B2i Digital CEO David Shapiro, who emphasized the value of direct access to management teams paired with independent research from Zacks. Presenting companies include Protalix BioTherapeutics, CytoSorbents, Jaguar Health, Reviva Pharmaceuticals, 4DMedical, Prostatype Genomics, Abingdon Health, Innovotech, Lakewood-Amedex, Nasus Pharma, Kelyniam Global, IMUNON, Promino Nutritional Sciences, Envoy Medical, Coiled Therapeutics, Aspire Biopharma, Rocket Doctor AI, Phio Pharmaceuticals, aTyr Pharma, and NuFarm. Each company will deliver a 30-minute live presentation with Q&A, and one-on-one meetings can be requested via the VIC site. Replays will be available on B2i Digital and OTC Markets YouTube channels. The event is accessible through the NEWMEDIAWIRE release, and registration is available at the Virtual Investor Conferences website. B2i Digital, founded in 2021 by David Shapiro, acts as The Capital Markets Matchmaker, connecting investors and companies through digital marketing and conferences. Zacks Small-Cap Research provides independent research, while Virtual Investor Conferences is an OTC Markets Group property. This forum offers a unique opportunity for investors to engage with life sciences innovators and make informed decisions.